{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:18:25Z","timestamp":1791861505450,"version":"4.3.4"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["#21\/2551-0001966-2"],"award-info":[{"award-number":["#21\/2551-0001966-2"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304985\/2020-1"],"award-info":[{"award-number":["304985\/2020-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#150611\/2022-6"],"award-info":[{"award-number":["#150611\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["process #23038.002125\/2021-85"],"award-info":[{"award-number":["process #23038.002125\/2021-85"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Grant #0036\/2021"],"award-info":[{"award-number":["Grant #0036\/2021"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["#88882.182170\/2018-01"],"award-info":[{"award-number":["#88882.182170\/2018-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10787-023-01160-w","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T18:02:52Z","timestamp":1677520972000},"page":"633-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?"],"prefix":"10.1007","volume":"31","author":[{"given":"Maria Fernanda Pessano","family":"Fialho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne Silva","family":"Brum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2960-5284","authenticated-orcid":false,"given":"Sara Marchesan","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"1160_CR1","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"O Abani","year":"2021","unstructured":"Abani O, Abbas A, Abbas F et al (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397:1637\u20131645. https:\/\/doi.org\/10.1016\/S0140-6736(21)00676-0","journal-title":"Lancet"},{"key":"1160_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fneur.2020.00687","volume":"11","author":"A Abdullahi","year":"2020","unstructured":"Abdullahi A, Candan SA, Abba MA et al (2020) Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Front Neurol 11:72\u201383. https:\/\/doi.org\/10.3389\/fneur.2020.00687","journal-title":"Front Neurol"},{"key":"1160_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.825749","volume":"13","author":"E Abidi","year":"2022","unstructured":"Abidi E, El Nekidy WS, Alefishat E et al (2022) Tocilizumab and COVID-19: timing of administration and efficacy. Front Pharmacol 13:1\u201312. https:\/\/doi.org\/10.3389\/fphar.2022.825749","journal-title":"Front Pharmacol"},{"key":"1160_CR4","doi-asserted-by":"publisher","first-page":"C57","DOI":"10.1152\/ajpcell.00426.2020","volume":"320","author":"S Ajaz","year":"2021","unstructured":"Ajaz S, McPhail MJ, Singh KK et al (2021) Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Physiol 320:C57\u2013C65. https:\/\/doi.org\/10.1152\/ajpcell.00426.2020","journal-title":"Am J Physiol Physiol"},{"key":"1160_CR5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s13365-020-00887-4","volume":"26","author":"F Aksan","year":"2020","unstructured":"Aksan F, Nelson EA, Swedish KA (2020) A COVID-19 patient with intense burning pain. J Neurovirol 26:800\u2013801. https:\/\/doi.org\/10.1007\/s13365-020-00887-4","journal-title":"J Neurovirol"},{"key":"1160_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbi.2018.09.018","volume":"75","author":"DS Albrecht","year":"2019","unstructured":"Albrecht DS, Forsberg A, Sandstr\u00f6m A et al (2019) Brain glial activation in fibromyalgia\u2014a multi-site positron emission tomography investigation. Brain Behav Immun 75:72\u201383. https:\/\/doi.org\/10.1016\/j.bbi.2018.09.018","journal-title":"Brain Behav Immun"},{"key":"1160_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.55563\/clinexprheumatol\/rxk6s4","volume":"130","author":"V Aloush","year":"2021","unstructured":"Aloush V, Gurfinkel A, Shachar N et al (2021) Physical and mental impact of COVID-19 outbreak on fibromyalgia patients. Clin Exp Rheumatol 130:108\u2013114","journal-title":"Clin Exp Rheumatol"},{"key":"1160_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/PR9.0000000000000884","volume":"6","author":"N Attal","year":"2021","unstructured":"Attal N, Martinez V, Bouhassira D (2021) Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. PAIN Reports 6:884. https:\/\/doi.org\/10.1097\/PR9.0000000000000884","journal-title":"PAIN Reports"},{"key":"1160_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41398-018-0206-7","volume":"8","author":"DR Bach","year":"2018","unstructured":"Bach DR, Korn CW, Vunder J, Bantel A (2018) Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial. Transl Psychiatry 8:157. https:\/\/doi.org\/10.1038\/s41398-018-0206-7","journal-title":"Transl Psychiatry"},{"key":"1160_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/J.1476-5381.2010.01199.X","volume":"163","author":"PJ Barnes","year":"2011","unstructured":"Barnes PJ (2011) Glucocorticosteroids: current and future directions. Br J Pharmacol 163:29\u201343. https:\/\/doi.org\/10.1111\/J.1476-5381.2010.01199.X","journal-title":"Br J Pharmacol"},{"key":"1160_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.0013-9580.2004.455003.x","volume":"45","author":"E Ben-Menachem","year":"2004","unstructured":"Ben-Menachem E (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45:13\u201318. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.455003.x","journal-title":"Epilepsia"},{"key":"1160_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopha.2018.04.056","volume":"103","author":"G Bj\u00f8rklund","year":"2018","unstructured":"Bj\u00f8rklund G, Dadar M, Chirumbolo S, Aaseth J (2018) Fibromyalgia and nutrition: therapeutic possibilities? Biomed Pharmacother 103:531\u2013538. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.056","journal-title":"Biomed Pharmacother"},{"key":"1160_CR13","doi-asserted-by":"publisher","first-page":"19923","DOI":"10.18632\/aging.104117","volume":"12","author":"J Blanch-Rubi\u00f3","year":"2020","unstructured":"Blanch-Rubi\u00f3 J, Soldevila-Domenech N, T\u00edo L et al (2020) Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions. Aging 12:19923\u201319937. https:\/\/doi.org\/10.18632\/aging.104117","journal-title":"Aging"},{"key":"1160_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"HN Bockbrader","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R et al (2010) A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 49:661\u2013669. https:\/\/doi.org\/10.2165\/11536200-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"1160_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","volume":"78","author":"M Boldrini","year":"2021","unstructured":"Boldrini M, Canoll PD, Klein RS (2021) How COVID-19 Affects the Brain. JAMA Psychiat 78:682. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0500","journal-title":"JAMA Psychiat"},{"key":"1160_CR16","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1172\/JCI141772","volume":"130","author":"V Bronte","year":"2020","unstructured":"Bronte V, Ugel S, Tinazzi E et al (2020) Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest 130:6409\u20136416. https:\/\/doi.org\/10.1172\/JCI141772","journal-title":"J Clin Invest"},{"key":"1160_CR17","first-page":"3786","volume-title":"The cochrane database of systematic reviews (Protocol)","author":"A Busch","year":"2002","unstructured":"Busch A, Barber K, Overend T et al (2002) Exercise for treating fibromyalgia syndrome. In: Busch A (ed) The cochrane database of systematic reviews (Protocol). John Wiley & Sons, Ltd, Chichester, p 3786"},{"key":"1160_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.autrev.2008.07.023","volume":"8","author":"D Buskila","year":"2008","unstructured":"Buskila D, Atzeni F, Sarzi-Puttini P (2008) Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev 8:41\u201343. https:\/\/doi.org\/10.1016\/j.autrev.2008.07.023","journal-title":"Autoimmun Rev"},{"key":"1160_CR19","doi-asserted-by":"publisher","first-page":"106053","DOI":"10.1016\/J.PHRS.2021.106053","volume":"176","author":"E Caiazzo","year":"2022","unstructured":"Caiazzo E, Rezig AOM, Bruzzese D et al (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacol Res 176:106053. https:\/\/doi.org\/10.1016\/J.PHRS.2021.106053","journal-title":"Pharmacol Res"},{"key":"1160_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s42358-021-00200-9","volume":"61","author":"D Cankurtaran","year":"2021","unstructured":"Cankurtaran D, Tezel N, Ercan B et al (2021) The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study. Adv Rheumatol 61:41. https:\/\/doi.org\/10.1186\/s42358-021-00200-9","journal-title":"Adv Rheumatol"},{"key":"1160_CR21","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.chest.2020.10.054","volume":"159","author":"EJ Cano","year":"2021","unstructured":"Cano EJ, Fonseca Fuentes X, Corsini Campioli C et al (2021) Impact of corticosteroids in coronavirus disease 2019 outcomes. Chest 159:1019\u20131040. https:\/\/doi.org\/10.1016\/j.chest.2020.10.054","journal-title":"Chest"},{"key":"1160_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L, Ojha R, Pedro LD et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370:856\u2013860. https:\/\/doi.org\/10.1126\/science.abd2985","journal-title":"Science"},{"key":"1160_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/J.JACI.2020.05.019","volume":"146","author":"Y Cao","year":"2020","unstructured":"Cao Y, Wei J, Zou L et al (2020) Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol 146:137-146.e3. https:\/\/doi.org\/10.1016\/J.JACI.2020.05.019","journal-title":"J Allergy Clin Immunol"},{"key":"1160_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec A, Bernabei R, Landi F (2020) Persistent symptoms in patients after acute COVID-19. JAMA 324:603\u2013605. https:\/\/doi.org\/10.1001\/jama.2020.12603","journal-title":"JAMA"},{"key":"1160_CR25","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, De Luca G, Campochiaro C et al (2020) Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol 2:e325\u2013e331. https:\/\/doi.org\/10.1016\/S2665-9913(20)30127-2","journal-title":"Lancet Rheumatol"},{"key":"1160_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/rheumatology\/keaa738","volume":"60","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Cariddi A, Ferrari J et al (2021) Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients. Rheumatol 60:465\u2013467. https:\/\/doi.org\/10.1093\/rheumatology\/keaa738","journal-title":"Rheumatol"},{"key":"1160_CR27","doi-asserted-by":"publisher","first-page":"110102","DOI":"10.1016\/J.MEHY.2020.110102","volume":"143","author":"R Cecchini","year":"2020","unstructured":"Cecchini R, Cecchini AL (2020) SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med Hypotheses 143:110102. https:\/\/doi.org\/10.1016\/J.MEHY.2020.110102","journal-title":"Med Hypotheses"},{"key":"1160_CR28","doi-asserted-by":"publisher","first-page":"57885","DOI":"10.1136\/BMJOPEN-2021-057885","volume":"12","author":"JS Chandan","year":"2022","unstructured":"Chandan JS, Brown K, Simms-Williams N et al (2022) Protocol: non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol. BMJ Open 12:57885. https:\/\/doi.org\/10.1136\/BMJOPEN-2021-057885","journal-title":"BMJ Open"},{"key":"1160_CR29","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2021.210142","author":"S Chang","year":"2021","unstructured":"Chang S, Minn D, Kim S-W, Kim Y (2021) Inflammatory Markers and Cytokines in Moderate and Critical Cases of COVID-19. Clin Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210142","journal-title":"Clin Lab"},{"key":"1160_CR30","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W et al (2020a) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130:2620\u20132629. https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"1160_CR31","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","volume":"71","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao B, Qu Y et al (2020b) Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically Ill patients with coronavirus disease 2019. Clin Infect Dis 71:1937\u20131942. https:\/\/doi.org\/10.1093\/cid\/ciaa449","journal-title":"Clin Infect Dis"},{"key":"1160_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrrheum.2015.56","volume":"11","author":"EHS Choy","year":"2015","unstructured":"Choy EHS (2015) The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol 11:513\u2013520. https:\/\/doi.org\/10.1038\/nrrheum.2015.56","journal-title":"Nat Rev Rheumatol"},{"key":"1160_CR33","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw DJ (2014) Fibromyalgia. JAMA 311:1547. https:\/\/doi.org\/10.1001\/jama.2014.3266","journal-title":"JAMA"},{"key":"1160_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","volume":"90","author":"DJ Clauw","year":"2015","unstructured":"Clauw DJ (2015) Fibromyalgia and related conditions. Mayo Clin Proc 90:680\u2013692. https:\/\/doi.org\/10.1016\/j.mayocp.2015.03.014","journal-title":"Mayo Clin Proc"},{"key":"1160_CR35","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1097\/j.pain.0000000000001950","volume":"161","author":"DJ Clauw","year":"2020","unstructured":"Clauw DJ, H\u00e4user W, Cohen SP, Fitzcharles M-A (2020) Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain 161:1694\u20131697. https:\/\/doi.org\/10.1097\/j.pain.0000000000001950","journal-title":"Pain"},{"key":"1160_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/JAMAINTERNMED.2021.6759","volume":"182","author":"BM Clemency","year":"2022","unstructured":"Clemency BM, Varughese R, Gonzalez-Rojas Y et al (2022) Efficacy of inhaled ciclesonide for outpatient treatment of adolescents and adults with symptomatic COVID-19: a randomized clinical trial. JAMA Intern Med 182:42\u201349. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2021.6759","journal-title":"JAMA Intern Med"},{"key":"1160_CR37","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/ar2918","volume":"12","author":"MD Cordero","year":"2010","unstructured":"Cordero MD, De Miguel M, Moreno Fern\u00e1ndez AM et al (2010) Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther 12:R17. https:\/\/doi.org\/10.1186\/ar2918","journal-title":"Arthritis Res Ther"},{"key":"1160_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.pone.0035677","volume":"7","author":"MD Cordero","year":"2012","unstructured":"Cordero MD, Cano-Garc\u00eda FJ, Alcocer-G\u00f3mez E et al (2012a) Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q 10 effect on clinical improvement. PLoS ONE 7:6\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0035677","journal-title":"PLoS ONE"},{"key":"1160_CR39","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.nut.2012.03.018","volume":"28","author":"MD Cordero","year":"2012","unstructured":"Cordero MD, Cot\u00e1n D, del-Pozo-Mart\u00edn Y et al (2012b) Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition 28:1200\u20131203. https:\/\/doi.org\/10.1016\/j.nut.2012.03.018","journal-title":"Nutrition"},{"key":"1160_CR40","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1089\/ars.2013.5198","volume":"20","author":"MD Cordero","year":"2014","unstructured":"Cordero MD, Alcocer-G\u00f3mez E, Culic O et al (2014) NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q 10. Antioxid Redox Signal 20:1169\u20131180. https:\/\/doi.org\/10.1089\/ars.2013.5198","journal-title":"Antioxid Redox Signal"},{"key":"1160_CR41","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2106\/JBJS.20.00847","volume":"102","author":"NP Disser","year":"2020","unstructured":"Disser NP, De Micheli AJ, Schonk MM et al (2020) Musculoskeletal consequences of COVID-19. J Bone Jt Surg - Am 102:1197\u20131204. https:\/\/doi.org\/10.2106\/JBJS.20.00847","journal-title":"J Bone Jt Surg - Am"},{"key":"1160_CR42","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.3389\/FMICB.2022.1037467\/BIBTEX","volume":"13","author":"AAC dos Santos","year":"2022","unstructured":"dos Santos AAC, Rodrigues LE, Alecrim-Zeza AL et al (2022) Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2. Front Microbiol 13:4553. https:\/\/doi.org\/10.3389\/FMICB.2022.1037467\/BIBTEX","journal-title":"Front Microbiol"},{"key":"1160_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2022.103071","author":"A Dotan","year":"2022","unstructured":"Dotan A, David P, Arnheim D, Shoenfeld Y (2022) The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. https:\/\/doi.org\/10.1016\/J.AUTREV.2022.103071","journal-title":"Autoimmun Rev"},{"key":"1160_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/07315724.1994.10718387","volume":"13","author":"J Eisinger","year":"1994","unstructured":"Eisinger J, Plantamura A, Ayavou T (1994) Glycolysis abnormalities in fibromyalgia. J Am Coll Nutr 13:144\u2013148. https:\/\/doi.org\/10.1080\/07315724.1994.10718387","journal-title":"J Am Coll Nutr"},{"key":"1160_CR45","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.2147\/IJGM.S323316","volume":"14","author":"M Elkan","year":"2021","unstructured":"Elkan M, Dvir A, Zaidenstein R et al (2021) Patient-reported outcome measures after hospitalization during the COVID-19 pandemic: a survey among COVID-19 and non-COVID-19 patients. Int J Gen Med 14:4829\u20134836. https:\/\/doi.org\/10.2147\/IJGM.S323316","journal-title":"Int J Gen Med"},{"key":"1160_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2213-2600(22)00006-6","volume":"10","author":"EW Ely","year":"2022","unstructured":"Ely EW, Ramanan AV, Kartman CE et al (2022) Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. Lancet Respir Med 10:327\u2013336. https:\/\/doi.org\/10.1016\/S2213-2600(22)00006-6","journal-title":"Lancet Respir Med"},{"key":"1160_CR47","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ana.25565","volume":"86","author":"D Evdokimov","year":"2019","unstructured":"Evdokimov D, Frank J, Klitsch A et al (2019) Reduction of skin innervation is associated with a severe fibromyalgia phenotype. Ann Neurol 86:504\u2013516. https:\/\/doi.org\/10.1002\/ana.25565","journal-title":"Ann Neurol"},{"key":"1160_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/NEUROLINT13040049","volume":"13","author":"D Fanelli","year":"2021","unstructured":"Fanelli D, Weller G, Liu H (2021) New serotonin-norepinephrine reuptake inhibitors and their anesthetic and analgesic considerations. Neurol Int 13:497\u2013509. https:\/\/doi.org\/10.3390\/NEUROLINT13040049","journal-title":"Neurol Int"},{"key":"1160_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001920","author":"A Fasolino","year":"2020","unstructured":"Fasolino A, Di Stefano G, Leone C et al (2020) Small-fibre pathology has no impact on somatosensory system function in patients with fibromyalgia. Pain Publish Ah: https:\/\/doi.org\/10.1097\/j.pain.0000000000001920","journal-title":"Pain Publish Ah:"},{"key":"1160_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002564","author":"C Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-las-Pe\u00f1as C, De-la-Llave-Rinc\u00f3n AI, Ortega-Santiago R et al (2021a) Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors. Pain. https:\/\/doi.org\/10.1097\/j.pain.0000000000002564","journal-title":"Pain"},{"key":"1160_CR51","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1097\/j.pain.0000000000002306","volume":"162","author":"C Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-las-Pe\u00f1as C, Rodr\u00edguez-Jim\u00e9nez J, Fuensalida-Novo S et al (2021b) Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. Pain 162:2832\u20132840. https:\/\/doi.org\/10.1097\/j.pain.0000000000002306","journal-title":"Pain"},{"key":"1160_CR52","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1097\/j.pain.0000000000002496","volume":"163","author":"C Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2022","unstructured":"Fern\u00e1ndez-de-las-Pe\u00f1as C, Navarro-Santana M, Plaza-Manzano G et al (2022) Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain 163:1220\u20131231. https:\/\/doi.org\/10.1097\/j.pain.0000000000002496","journal-title":"Pain"},{"key":"1160_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/j.pain.0000000000002718","volume":"164","author":"C Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2023","unstructured":"Fern\u00e1ndez-de-las-Pe\u00f1as C, Cancela-Cilleruelo I, Moro-L\u00f3pez-Menchero P et al (2023) Exploring the trajectory curve of long-term musculoskeletal post-COVID pain symptoms in hospitalized COVID-19 survivors: a multicenter study. Pain 164:413\u2013420. https:\/\/doi.org\/10.1097\/j.pain.0000000000002718","journal-title":"Pain"},{"key":"1160_CR54","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"M-A Fitzcharles","year":"2021","unstructured":"Fitzcharles M-A, Cohen SP, Clauw DJ et al (2021) Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397:2098\u20132110. https:\/\/doi.org\/10.1016\/S0140-6736(21)00392-5","journal-title":"Lancet"},{"key":"1160_CR55","doi-asserted-by":"publisher","first-page":"654813","DOI":"10.3389\/fcimb.2021.654813","volume":"11","author":"GE Forcados","year":"2021","unstructured":"Forcados GE, Muhammad A, Oladipo OO et al (2021) Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: therapeutic potential of natural antioxidants. Front Cell Infect Microbiol 11:654813. https:\/\/doi.org\/10.3389\/fcimb.2021.654813","journal-title":"Front Cell Infect Microbiol"},{"key":"1160_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH19106323","author":"P Gentil","year":"2022","unstructured":"Gentil P, de Lira CAB, Vieira CA et al (2022) Resistance training before, during, and after COVID-19 infection: what have we learned so far? Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/IJERPH19106323","journal-title":"Int J Environ Res Public Health"},{"key":"1160_CR57","first-page":"129","volume":"16","author":"TA Gheita","year":"2021","unstructured":"Gheita TA, Fathi HM, Eladle SS et al (2021) Coronavirus disease 2019 ( COVID-19) an emerging trigger for primary fibromyalgia syndrome\u202f: a tale of three cases post-COVID-19. Int J Clin Rheumtol 16:129\u2013135","journal-title":"Int J Clin Rheumtol"},{"key":"1160_CR58","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/J.CHOM.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Netea MG, Rovina N et al (2020) Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27:992-1000.e3. https:\/\/doi.org\/10.1016\/J.CHOM.2020.04.009","journal-title":"Cell Host Microbe"},{"key":"1160_CR59","doi-asserted-by":"publisher","first-page":"e0270668","DOI":"10.1371\/JOURNAL.PONE.0270668","volume":"17","author":"PJ Godolphin","year":"2022","unstructured":"Godolphin PJ, Fisher DJ, Berry LR et al (2022) Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: a network meta-analysis. PLoS ONE 17:e0270668. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0270668","journal-title":"PLoS ONE"},{"key":"1160_CR60","doi-asserted-by":"publisher","first-page":"144201","DOI":"10.1172\/JCI144201","volume":"131","author":"A Goebel","year":"2021","unstructured":"Goebel A, Krock E, Gentry C et al (2021) Passive transfer of fibromyalgia symptoms from patients to mice. J Clin Invest 131:144201. https:\/\/doi.org\/10.1172\/JCI144201","journal-title":"J Clin Invest"},{"key":"1160_CR61","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1007\/S00415-022-11225-5\/TABLES\/4","volume":"269","author":"A Gonzalez-Martinez","year":"2022","unstructured":"Gonzalez-Martinez A, Guerrero-Peral \u00c1L, Arias-Rivas S et al (2022) Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors. J Neurol 269:5702\u20135709. https:\/\/doi.org\/10.1007\/S00415-022-11225-5\/TABLES\/4","journal-title":"J Neurol"},{"key":"1160_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/JCM10235594","author":"L Goudman","year":"2021","unstructured":"Goudman L, De Smedt A, Noppen M, Moens M (2021) Is central sensitisation the missing link of persisting symptoms after COVID-19 infection? J Clin Med. https:\/\/doi.org\/10.3390\/JCM10235594","journal-title":"J Clin Med"},{"key":"1160_CR63","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/acn3.51350","volume":"8","author":"EL Graham","year":"2021","unstructured":"Graham EL, Clark JR, Orban ZS et al (2021) Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \u201clong haulers.\u201d Ann Clin Transl Neurol 8:1073\u20131085. https:\/\/doi.org\/10.1002\/acn3.51350","journal-title":"Ann Clin Transl Neurol"},{"key":"1160_CR64","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"1160_CR65","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","volume":"268","author":"BN Harapan","year":"2021","unstructured":"Harapan BN, Yoo HJ (2021) Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol 268:3059\u20133071. https:\/\/doi.org\/10.1007\/s00415-021-10406-y","journal-title":"J Neurol"},{"key":"1160_CR66","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/JIR.S219586","volume":"13","author":"R Harrington","year":"2020","unstructured":"Harrington R, Al Nokhatha SA, Conway R (2020) JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data. J Inflamm Res 13:519. https:\/\/doi.org\/10.2147\/JIR.S219586","journal-title":"J Inflamm Res"},{"key":"1160_CR67","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","volume":"1","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user W, Ablin J, Fitzcharles M-A et al (2015) Fibromyalgia. Nat Rev Dis Prim 1:15022. https:\/\/doi.org\/10.1038\/nrdp.2015.22","journal-title":"Nat Rev Dis Prim"},{"key":"1160_CR68","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/PR9.0000000000000598","volume":"2","author":"W H\u00e4user","year":"2017","unstructured":"H\u00e4user W, Perrot S, Sommer C et al (2017) Diagnostic confounders of chronic widespread pain: not always fibromyalgia. PAIN Reports 2:598. https:\/\/doi.org\/10.1097\/PR9.0000000000000598","journal-title":"PAIN Reports"},{"key":"1160_CR69","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/JAMA.2022.0040","volume":"327","author":"H Heesakkers","year":"2022","unstructured":"Heesakkers H, Van Der Hoeven JG, Corsten S et al (2022) Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA 327:559\u2013565. https:\/\/doi.org\/10.1001\/JAMA.2022.0040","journal-title":"JAMA"},{"key":"1160_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJERPH18042075","volume":"18","author":"I Hernando-Garijo","year":"2021","unstructured":"Hernando-Garijo I, Ceballos-Laita L, Mingo-G\u00f3mez MT et al (2021) Immediate effects of a telerehabilitation program based on aerobic exercise in women with fibromyalgia. Int J Environ Res Public Health 18:1\u201312. https:\/\/doi.org\/10.3390\/IJERPH18042075","journal-title":"Int J Environ Res Public Health"},{"key":"1160_CR71","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S2213-2600(21)00435-5","volume":"9","author":"PW Horby","year":"2021","unstructured":"Horby PW, Martin P, Landray J (2021) Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med 9:1419\u20131426. https:\/\/doi.org\/10.1016\/S2213-2600(21)00435-5","journal-title":"Lancet Respir Med"},{"key":"1160_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41572-020-0201-1","volume":"6","author":"MM Hosey","year":"2020","unstructured":"Hosey MM, Needham DM (2020) Survivorship after COVID-19 ICU stay. Nat Rev Dis Prim 6:60. https:\/\/doi.org\/10.1038\/s41572-020-0201-1","journal-title":"Nat Rev Dis Prim"},{"key":"1160_CR73","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJME2032071\/SUPPL_FILE\/NEJME2032071_DISCLOSURES.PDF","volume":"383","author":"E Huang","year":"2020","unstructured":"Huang E, Jordan SC (2020) Tocilizumab for Covid-19 \u2014 the ongoing search for effective therapies. N Engl J Med 383:2387\u20132388. https:\/\/doi.org\/10.1056\/NEJME2032071\/SUPPL_FILE\/NEJME2032071_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"1160_CR74","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y et al (2021a) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397:220\u2013232. https:\/\/doi.org\/10.1016\/S0140-6736(20)32656-8","journal-title":"Lancet"},{"key":"1160_CR75","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","volume":"398","author":"L Huang","year":"2021","unstructured":"Huang L, Yao Q, Gu X et al (2021b) 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 398:747\u2013758. https:\/\/doi.org\/10.1016\/S0140-6736(21)01755-4","journal-title":"Lancet"},{"key":"1160_CR76","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","volume":"2","author":"T Huet","year":"2020","unstructured":"Huet T, Beaussier H, Voisin O et al (2020) Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol 2:e393\u2013e400. https:\/\/doi.org\/10.1016\/S2665-9913(20)30164-8","journal-title":"Lancet Rheumatol"},{"key":"1160_CR77","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1136\/annrheumdis-2020-218329","volume":"79","author":"C-H Hung","year":"2020","unstructured":"Hung C-H, Lee C-H, Tsai M-H et al (2020) Activation of acid-sensing ion channel 3 by lysophosphatidylcholine 16:0 mediates psychological stress-induced fibromyalgia-like pain. Ann Rheum Dis 79:1644\u20131656. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218329","journal-title":"Ann Rheum Dis"},{"key":"1160_CR78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.55563\/clinexprheumatol\/4nb0ku","volume":"39","author":"C Iannuccelli","year":"2021","unstructured":"Iannuccelli C, Lucchino B, Gioia C et al (2021) Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis. Clin Exp Rheumatol 39:153\u2013160","journal-title":"Clin Exp Rheumatol"},{"key":"1160_CR79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ams2.415","volume":"6","author":"S Inoue","year":"2019","unstructured":"Inoue S, Hatakeyama J, Kondo Y et al (2019) Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg 6:233\u2013246. https:\/\/doi.org\/10.1002\/ams2.415","journal-title":"Acute Med Surg"},{"key":"1160_CR80","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/J.ARRCT.2022.100188","volume":"4","author":"D Jena","year":"2022","unstructured":"Jena D, Sahoo J, Barman A et al (2022) Neuropathic pain in hospitalized patients with COVID-19: a prospective case series. Arch Rehabil Res Clin Transl. 4:100188. https:\/\/doi.org\/10.1016\/J.ARRCT.2022.100188","journal-title":"Arch Rehabil Res Clin Transl."},{"key":"1160_CR81","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"RR Ji","year":"2018","unstructured":"Ji RR, Nackley A, Huh Y et al (2018) Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology 129:343\u2013366. https:\/\/doi.org\/10.1097\/ALN.0000000000002130","journal-title":"Anesthesiology"},{"key":"1160_CR82","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jama.2020.14254","volume":"324","author":"SA Josephson","year":"2020","unstructured":"Josephson SA, Kamel H (2020) Neurology and COVID-19. JAMA 324:1139. https:\/\/doi.org\/10.1001\/jama.2020.14254","journal-title":"JAMA"},{"key":"1160_CR83","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMOA2031994\/SUPPL_FILE\/NEJMOA2031994_DATA-SHARING.PDF","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil AC, Patterson TF, Mehta AK et al (2021) Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med 384:795\u2013807. https:\/\/doi.org\/10.1056\/NEJMOA2031994\/SUPPL_FILE\/NEJMOA2031994_DATA-SHARING.PDF","journal-title":"N Engl J Med"},{"key":"1160_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S10254-003-0012-2","volume":"149","author":"D Kamimura","year":"2003","unstructured":"Kamimura D, Ishihara K, Hirano T (2003) IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149:1\u201338. https:\/\/doi.org\/10.1007\/S10254-003-0012-2","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"1160_CR85","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/j.pain.0000000000002004","volume":"161","author":"K Karos","year":"2020","unstructured":"Karos K, McParland JL, Bunzli S et al (2020) The social threats of COVID-19 for people with chronic pain. Pain 161:2229\u20132235. https:\/\/doi.org\/10.1097\/j.pain.0000000000002004","journal-title":"Pain"},{"key":"1160_CR86","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1002\/jmv.27198","volume":"93","author":"B Kayaaslan","year":"2021","unstructured":"Kayaaslan B, Eser F, Kalem AK et al (2021) Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol 93:6566\u20136574. https:\/\/doi.org\/10.1002\/jmv.27198","journal-title":"J Med Virol"},{"key":"1160_CR87","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1016\/j.bja.2019.03.025","volume":"123","author":"HI Kemp","year":"2019","unstructured":"Kemp HI, Laycock H, Costello A, Brett SJ (2019) Chronic pain in critical care survivors\u202f: a narrative review. Br J Anaesth 123:e372\u2013e384. https:\/\/doi.org\/10.1016\/j.bja.2019.03.025","journal-title":"Br J Anaesth"},{"key":"1160_CR88","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.bja.2020.05.021","volume":"125","author":"HI Kemp","year":"2020","unstructured":"Kemp HI, Corner E, Colvin LA (2020) Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth 125:436\u2013440. https:\/\/doi.org\/10.1016\/j.bja.2020.05.021","journal-title":"Br J Anaesth"},{"key":"1160_CR89","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2022.2139317","author":"K Kirito","year":"2022","unstructured":"Kirito K (2022) Recent progress of JAK inhibitors for hematological disorders. Immunol Med. https:\/\/doi.org\/10.1080\/25785826.2022.2139317","journal-title":"Immunol Med"},{"key":"1160_CR90","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.molmed.2021.06.002","volume":"27","author":"AL Komaroff","year":"2021","unstructured":"Komaroff AL, Lipkin WI (2021) Insights from myalgic encephalomyelitis\/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med 27:895\u2013906. https:\/\/doi.org\/10.1016\/j.molmed.2021.06.002","journal-title":"Trends Mol Med"},{"key":"1160_CR91","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1097\/J.PAIN.0000000000002324","volume":"162","author":"E Kosek","year":"2021","unstructured":"Kosek E, Clauw D, Nijs J et al (2021) Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain 162:2629\u20132634. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000002324","journal-title":"Pain"},{"key":"1160_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/20018525.2021.1945186","author":"S Kostorz-Nosal","year":"2021","unstructured":"Kostorz-Nosal S, Jastrz\u0119bski D, Chyra M et al (2021) A prolonged steroid therapy may be beneficial in some patients after the COVID-19 pneumonia. Eur Clin Respir J. https:\/\/doi.org\/10.1080\/20018525.2021.1945186","journal-title":"Eur Clin Respir J"},{"key":"1160_CR93","doi-asserted-by":"publisher","first-page":"737","DOI":"10.18502\/IJM.V13I6.8072","volume":"13","author":"I Krynytska","year":"2021","unstructured":"Krynytska I, Marushchak M, Birchenko I et al (2021) COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review). Iran J Microbiol. 13:737. https:\/\/doi.org\/10.18502\/IJM.V13I6.8072","journal-title":"Iran J Microbiol."},{"key":"1160_CR94","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s10067-020-05178-1","volume":"39","author":"A Kucuk","year":"2020","unstructured":"Kucuk A, Cumhur Cure M, Cure E (2020) Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin Rheumatol 39:2103\u20132104. https:\/\/doi.org\/10.1007\/s10067-020-05178-1","journal-title":"Clin Rheumatol"},{"key":"1160_CR95","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/J.CSBJ.2020.12.028","volume":"19","author":"A Kumar","year":"2021","unstructured":"Kumar A, Loharch S, Kumar S et al (2021) Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2. Comput Struct Biotechnol J 19:424\u2013438. https:\/\/doi.org\/10.1016\/J.CSBJ.2020.12.028","journal-title":"Comput Struct Biotechnol J"},{"issue":"12","key":"1160_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-17082-6","volume":"121","author":"O Kutkat","year":"2022","unstructured":"Kutkat O, Moatasim Y, Al-Karmalawy AA et al (2022) Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies. Sci Rep 121(12):1\u201312. https:\/\/doi.org\/10.1038\/s41598-022-17082-6","journal-title":"Sci Rep"},{"key":"1160_CR97","doi-asserted-by":"publisher","first-page":"m3379","DOI":"10.1136\/bmj.m3379","volume":"370","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Agarwal A, Rochwerg B et al (2020) A living WHO guideline on drugs for covid-19. BMJ 370:m3379. https:\/\/doi.org\/10.1136\/bmj.m3379","journal-title":"BMJ"},{"key":"1160_CR98","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2020-217877","volume":"79","author":"RBM Landew\u00e9","year":"2020","unstructured":"Landew\u00e9 RBM, Machado PM, Kroon F et al (2020) EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis 79:851\u2013858. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217877","journal-title":"Ann Rheum Dis"},{"key":"1160_CR99","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/AJP.0b013e3182a0e383","volume":"30","author":"AA Larson","year":"2014","unstructured":"Larson AA, Pardo JV, Pasley JD (2014) Review of overlap between thermoregulation and pain modulation in fibromyalgia. Clin J Pain 30:544\u2013555. https:\/\/doi.org\/10.1097\/AJP.0b013e3182a0e383","journal-title":"Clin J Pain"},{"key":"1160_CR100","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbi.2020.05.037","volume":"88","author":"C Liguori","year":"2020","unstructured":"Liguori C, Pierantozzi M, Spanetta M et al (2020) Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun 88:11\u201316. https:\/\/doi.org\/10.1016\/j.bbi.2020.05.037","journal-title":"Brain Behav Immun"},{"key":"1160_CR101","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jad.2020.09.042","volume":"278","author":"C Liguori","year":"2021","unstructured":"Liguori C, Pierantozzi M, Spanetta M et al (2021) Depressive and anxiety symptoms in patients with SARS-CoV2 infection. J Affect Disord 278:339\u2013340. https:\/\/doi.org\/10.1016\/j.jad.2020.09.042","journal-title":"J Affect Disord"},{"key":"1160_CR102","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2015.100","volume":"11","author":"G Littlejohn","year":"2015","unstructured":"Littlejohn G (2015) Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nat Rev Rheumatol 11:639\u2013648. https:\/\/doi.org\/10.1038\/nrrheum.2015.100","journal-title":"Nat Rev Rheumatol"},{"key":"1160_CR103","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00281-018-0672-2","volume":"40","author":"G Littlejohn","year":"2018","unstructured":"Littlejohn G, Guymer E (2018) Neurogenic inflammation in fibromyalgia. Semin Immunopathol 40:291\u2013300. https:\/\/doi.org\/10.1007\/s00281-018-0672-2","journal-title":"Semin Immunopathol"},{"key":"1160_CR104","doi-asserted-by":"publisher","first-page":"e210830","DOI":"10.1001\/jamanetworkopen.2021.0830","volume":"4","author":"JK Logue","year":"2021","unstructured":"Logue JK, Franko NM, McCulloch DJ et al (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 4:e210830. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0830","journal-title":"JAMA Netw Open"},{"key":"1160_CR105","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/j.pain.0000000000000707","volume":"158","author":"M L\u00f3pez-Sol\u00e0","year":"2017","unstructured":"L\u00f3pez-Sol\u00e0 M, Woo C-W, Pujol J et al (2017) Towards a neurophysiological signature for fibromyalgia. Pain 158:34\u201347. https:\/\/doi.org\/10.1097\/j.pain.0000000000000707","journal-title":"Pain"},{"key":"1160_CR106","doi-asserted-by":"publisher","first-page":"155151","DOI":"10.1016\/j.cyto.2020.155151","volume":"133","author":"M Mahmudpour","year":"2020","unstructured":"Mahmudpour M, Roozbeh J, Keshavarz M et al (2020) COVID-19 cytokine storm: the anger of inflammation. Cytokine 133:155151. https:\/\/doi.org\/10.1016\/j.cyto.2020.155151","journal-title":"Cytokine"},{"key":"1160_CR107","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:683. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"key":"1160_CR108","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","volume":"9","author":"VC Marconi","year":"2021","unstructured":"Marconi VC, Ramanan AV, de Bono S et al (2021) Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med 9:1407\u20131418. https:\/\/doi.org\/10.1016\/S2213-2600(21)00331-3","journal-title":"Lancet Respir Med"},{"key":"1160_CR109","doi-asserted-by":"publisher","first-page":"e885","DOI":"10.1097\/PR9.0000000000000885","volume":"6","author":"AJ McFarland","year":"2021","unstructured":"McFarland AJ, Yousuf MS, Shiers S, Price TJ (2021) Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain Reports. 6:e885. https:\/\/doi.org\/10.1097\/PR9.0000000000000885","journal-title":"Pain Reports."},{"key":"1160_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2020.102537","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, Sharif K, O\u2019Regan A, Bridgewood C (2020) The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. https:\/\/doi.org\/10.1016\/J.AUTREV.2020.102537","journal-title":"Autoimmun Rev"},{"key":"1160_CR111","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1526-4637.2000.000024-48.x","volume":"1","author":"D McLain","year":"2000","unstructured":"McLain D (2000) The effects of tizanidine HCL (Zanaflex\u00ae) in patients with fibromyalgia. Pain Med 1:207\u2013207. https:\/\/doi.org\/10.1046\/j.1526-4637.2000.000024-48.x","journal-title":"Pain Med"},{"key":"1160_CR112","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1517\/14728222.2013.818657","volume":"17","author":"M Meeus","year":"2013","unstructured":"Meeus M, Nijs J, Hermans L et al (2013) The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opin Ther Targets 17:1081\u20131089. https:\/\/doi.org\/10.1517\/14728222.2013.818657","journal-title":"Expert Opin Ther Targets"},{"key":"1160_CR113","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/J.PAIN.0000000000002428","volume":"163","author":"A Meulders","year":"2022","unstructured":"Meulders A, Vlaeyen JWS, Evers AWM et al (2022) Chronic primary pain in the COVID-19 pandemic: how uncertainty and stress impact on functioning and suffering. Pain 163:604\u2013609. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000002428","journal-title":"Pain"},{"key":"1160_CR114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11910-021-01130-1","volume":"21","author":"N Moghimi","year":"2021","unstructured":"Moghimi N, Di Napoli M, Biller J et al (2021) The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep 21:44. https:\/\/doi.org\/10.1007\/s11910-021-01130-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1160_CR115","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/01.j.pain.0000460341.62094.77","volume":"156","author":"JS Mogil","year":"2015","unstructured":"Mogil JS (2015) Social modulation of and by pain in humans and rodents. Pain 156:S35\u2013S41. https:\/\/doi.org\/10.1097\/01.j.pain.0000460341.62094.77","journal-title":"Pain"},{"key":"1160_CR116","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.mayocpiqo.2020.08.002","volume":"4","author":"AB Mohabbat","year":"2020","unstructured":"Mohabbat AB, Mohabbat NML, Wight EC (2020) Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes 4:764\u2013766. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.08.002","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"1160_CR117","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27:601\u2013615. https:\/\/doi.org\/10.1038\/s41591-021-01283-z","journal-title":"Nat Med"},{"key":"1160_CR118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbi.2020.06.020","volume":"88","author":"K Nalleballe","year":"2020","unstructured":"Nalleballe K, Reddy Onteddu S, Sharma R et al (2020) Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun 88:71\u201374. https:\/\/doi.org\/10.1016\/j.bbi.2020.06.020","journal-title":"Brain Behav Immun"},{"key":"1160_CR119","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/art.27497","volume":"62","author":"V Napadow","year":"2010","unstructured":"Napadow V, LaCount L, Park K et al (2010) Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum 62:2545\u20132555. https:\/\/doi.org\/10.1002\/art.27497","journal-title":"Arthritis Rheum"},{"key":"1160_CR120","doi-asserted-by":"publisher","first-page":"e2111417","DOI":"10.1001\/jamanetworkopen.2021.11417","volume":"4","author":"T Nasserie","year":"2021","unstructured":"Nasserie T, Hittle M, Goodman SN (2021) Assessment of the frequency and variety of persistent symptoms among patients with COVID-19. JAMA Netw Open 4:e2111417. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.11417","journal-title":"JAMA Netw Open"},{"key":"1160_CR121","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/jmv.25826","volume":"92","author":"S Nataf","year":"2020","unstructured":"Nataf S (2020) An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J Med Virol 92:1743\u20131744. https:\/\/doi.org\/10.1002\/jmv.25826","journal-title":"J Med Virol"},{"key":"1160_CR122","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.7326\/M21-0878","volume":"174","author":"M Nehme","year":"2021","unstructured":"Nehme M, Braillard O, Chappuis F et al (2021) Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med 174:1252\u20131260. https:\/\/doi.org\/10.7326\/M21-0878","journal-title":"Ann Intern Med"},{"key":"1160_CR123","unstructured":"Department of Health, NHS (2021) Interim Clinical Commissioning Policy: IL-6 inhibitors (tocilizumab or sarilumab) for hospitalised patients with COVID-19 (adults). Rapid Policy Statement 1\u20135"},{"key":"1160_CR124","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/jcph.1878","volume":"61","author":"C Oddy","year":"2021","unstructured":"Oddy C, McCaul J, Keeling P et al (2021) Pharmacological predictors of morbidity and mortality in COVID-19. J Clin Pharmacol 61:1286\u20131300. https:\/\/doi.org\/10.1002\/jcph.1878","journal-title":"J Clin Pharmacol"},{"key":"1160_CR125","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.3390\/ijerph18136804","volume":"18","author":"T-K Oh","year":"2021","unstructured":"Oh T-K, Song I-A, Lee J et al (2021) Musculoskeletal disorders, pain medication, and in-hospital mortality among patients with COVID-19 in South Korea: a population-based cohort study. Int J Environ Res Public Health 18:6804. https:\/\/doi.org\/10.3390\/ijerph18136804","journal-title":"Int J Environ Res Public Health"},{"key":"1160_CR126","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray M, Abu Samra K, Ebrahimiadib N et al (2016) Long-term side effects of glucocorticoids. Expert Opin Drug Saf 15:457\u2013465","journal-title":"Expert Opin Drug Saf"},{"key":"1160_CR127","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11926-000-0053-3","volume":"2","author":"JH Park","year":"2000","unstructured":"Park JH, Niermann KJ, Olsen NJ (2000) Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Curr Rheumatol Rep 2:131\u2013140. https:\/\/doi.org\/10.1007\/s11926-000-0053-3","journal-title":"Curr Rheumatol Rep"},{"key":"1160_CR128","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.29271\/jcpsp.2021.Supp2.S143","volume":"31","author":"S Pektas","year":"2021","unstructured":"Pektas S, Gursoy C, Demirbilek SG (2021) The use of pregabalin in Intensive Care Unit in the treatment of Covid-19-related pain and cough. J Coll Physicians Surg Pak 31:S143\u2013S143. https:\/\/doi.org\/10.29271\/jcpsp.2021.Supp2.S143","journal-title":"J Coll Physicians Surg Pak"},{"key":"1160_CR129","doi-asserted-by":"publisher","first-page":"e912","DOI":"10.1097\/pr9.0000000000000912","volume":"6","author":"J Perez","year":"2021","unstructured":"Perez J, Niburski K, Stoopler M, Ingelmo P (2021) Telehealth and chronic pain management from rapid adaptation to long-term implementation in pain medicine: a narrative review. PAIN Reports. 6:e912. https:\/\/doi.org\/10.1097\/pr9.0000000000000912","journal-title":"PAIN Reports."},{"key":"1160_CR130","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/S1473-3099(22)00433","volume":"23","author":"N Perico","year":"2022","unstructured":"Perico N, Cortinovis M, Suter F, Remuzzi G (2022) Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents. Lancet Infect Dis 23:e22\u2013e33. https:\/\/doi.org\/10.1016\/S1473-3099(22)00433","journal-title":"Lancet Infect Dis"},{"key":"1160_CR131","doi-asserted-by":"publisher","DOI":"10.1055\/a-1492-3293","author":"BO Plasencia-Garc\u00eda","year":"2021","unstructured":"Plasencia-Garc\u00eda BO, Rico-Rangel MI, Rodr\u00edguez-Men\u00e9ndez G et al (2021) Drug-drug Interactions between COVID-19 treatments and antidepressants, mood stabilizers\/anticonvulsants, and benzodiazepines: integrated evidence from 3 databases. Pharmacopsychiatry. https:\/\/doi.org\/10.1055\/a-1492-3293","journal-title":"Pharmacopsychiatry"},{"key":"1160_CR132","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1541-7786.MCR-20-0814","volume":"19","author":"M Rada","year":"2021","unstructured":"Rada M, Qusairy Z, Massip-Salcedo M, Macip S (2021) Relevance of the bruton tyrosine kinase as a target for COVID-19 therapy. Mol Cancer Res 19:549\u2013554. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0814","journal-title":"Mol Cancer Res"},{"key":"1160_CR133","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RECOVERY CG,","year":"2021","unstructured":"RECOVERY CG, (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"1160_CR134","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/biom5020545","volume":"5","author":"M Rinnerthaler","year":"2015","unstructured":"Rinnerthaler M, Bischof J, Streubel MK et al (2015) Oxidative stress in aging human skin. Biomolecules 5:545\u2013589. https:\/\/doi.org\/10.3390\/biom5020545","journal-title":"Biomolecules"},{"key":"1160_CR135","doi-asserted-by":"publisher","DOI":"10.1126\/SCIIMMUNOL.ABD0110","author":"M Roschewski","year":"2020","unstructured":"Roschewski M, Lionakis MS, Sharman JP et al (2020) Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci Immunol. https:\/\/doi.org\/10.1126\/SCIIMMUNOL.ABD0110","journal-title":"Sci Immunol"},{"key":"1160_CR136","doi-asserted-by":"publisher","first-page":"e915","DOI":"10.1097\/PR9.0000000000000915","volume":"6","author":"MC Rowbotham","year":"2021","unstructured":"Rowbotham MC, Arendt-Nielsen L (2021) A year like no other: introduction to a special issue on COVID-19 and pain. PAIN Rep 6:e915. https:\/\/doi.org\/10.1097\/PR9.0000000000000915","journal-title":"PAIN Rep"},{"key":"1160_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.GENHOSPPSYCH.2021.02.006","volume":"70","author":"M Sabe","year":"2021","unstructured":"Sabe M, Dorsaz O, Huguelet P, Kaiser S (2021) Toxicity of psychotropic drugs in patients with COVID-19: a systematic review. Gen Hosp Psychiatry 70:1\u20139. https:\/\/doi.org\/10.1016\/J.GENHOSPPSYCH.2021.02.006","journal-title":"Gen Hosp Psychiatry"},{"key":"1160_CR138","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.55563\/clinexprheumatol\/dnxtch","volume":"39","author":"F Salaffi","year":"2021","unstructured":"Salaffi F, Giorgi V, Sirotti S et al (2021) The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clin Exp Rheumatol 39:S72\u2013S77","journal-title":"Clin Exp Rheumatol"},{"key":"1160_CR139","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMOA2030340","volume":"384","author":"C Salama","year":"2021","unstructured":"Salama C, Han J, Yau L et al (2021) Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med 384:20\u201330. https:\/\/doi.org\/10.1056\/NEJMOA2030340","journal-title":"N Engl J Med"},{"key":"1160_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2020.06.008","volume":"54","author":"J Saleh","year":"2020","unstructured":"Saleh J, Peyssonnaux C, Singh KK, Edeas M (2020) Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 54:1\u20137. https:\/\/doi.org\/10.1016\/j.mito.2020.06.008","journal-title":"Mitochondrion"},{"key":"1160_CR141","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","volume":"16","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F (2020) Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol 16:645\u2013660. https:\/\/doi.org\/10.1038\/s41584-020-00506-w","journal-title":"Nat Rev Rheumatol"},{"key":"1160_CR142","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s40121-021-00484-w","volume":"10","author":"M Scherlinger","year":"2021","unstructured":"Scherlinger M, Felten R, Gallais F et al (2021) Refining \u201cLong-COVID\u201d by a prospective multimodal evaluation of patients with long-term symptoms attributed to SARS-CoV-2 infection. Infect Dis Ther 10:1747\u20131763. https:\/\/doi.org\/10.1007\/s40121-021-00484-w","journal-title":"Infect Dis Ther"},{"key":"1160_CR143","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-020-0451-z","volume":"16","author":"G Schett","year":"2020","unstructured":"Schett G, Manger B, Simon D, Caporali R (2020) COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol 16:465\u2013470. https:\/\/doi.org\/10.1038\/s41584-020-0451-z","journal-title":"Nat Rev Rheumatol"},{"key":"1160_CR144","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/nu12030821","volume":"12","author":"V Schweiger","year":"2020","unstructured":"Schweiger V, Secchettin E, Castellani C et al (2020) Comparison between acupuncture and nutraceutical treatment with migratens\u00ae in patients with fibromyalgia syndrome: a prospective randomized clinical trial. Nutrients 12:821. https:\/\/doi.org\/10.3390\/nu12030821","journal-title":"Nutrients"},{"key":"1160_CR145","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1097\/j.pain.0000000000002051","volume":"161","author":"S Shiers","year":"2020","unstructured":"Shiers S, Ray PR, Wangzhou A et al (2020) ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects. Pain 161:2494\u20132501. https:\/\/doi.org\/10.1097\/j.pain.0000000000002051","journal-title":"Pain"},{"key":"1160_CR146","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/S40122-015-0036-8","volume":"4","author":"EE Shipton","year":"2015","unstructured":"Shipton EE, Shipton EA (2015) Vitamin D deficiency and pain: clinical evidence of low levels of vitamin D and supplementation in chronic pain states. Pain Ther 4:67. https:\/\/doi.org\/10.1007\/S40122-015-0036-8","journal-title":"Pain Ther"},{"key":"1160_CR147","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(18)31793-8","volume":"393","author":"A Slee","year":"2019","unstructured":"Slee A, Nazareth I, Bondaronek P et al (2019) Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 393:768\u2013777. https:\/\/doi.org\/10.1016\/S0140-6736(18)31793-8","journal-title":"Lancet"},{"key":"1160_CR148","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"Sterne JAC, Murthy S, Diaz JV et al (2020) Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA 324:1330\u20131341. https:\/\/doi.org\/10.1001\/jama.2020.17023","journal-title":"JAMA"},{"key":"1160_CR149","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/brainsci10110852","volume":"10","author":"L Tancheva","year":"2020","unstructured":"Tancheva L, Petralia MC, Miteva S et al (2020) Emerging neurological and psychobiological aspects of COVID-19 infection. Brain Sci 10:852. https:\/\/doi.org\/10.3390\/brainsci10110852","journal-title":"Brain Sci"},{"key":"1160_CR150","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","volume":"9","author":"JC Tardif","year":"2021","unstructured":"Tardif JC, Bouabdallaoui N, L\u2019Allier PL et al (2021) Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med 9:924\u2013932. https:\/\/doi.org\/10.1016\/S2213-2600(21)00222-8","journal-title":"Lancet Respir Med"},{"key":"1160_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2019.00353","volume":"13","author":"TC Theoharides","year":"2019","unstructured":"Theoharides TC, Tsilioni I, Bawazeer M (2019) Mast cells, neuroinflammation and pain in fibromyalgia syndrome. Front Cell Neurosci 13:1\u20138. https:\/\/doi.org\/10.3389\/fncel.2019.00353","journal-title":"Front Cell Neurosci"},{"key":"1160_CR152","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1513\/AnnalsATS.202009-1175OC","volume":"18","author":"L Townsend","year":"2021","unstructured":"Townsend L, Dowds J, O\u2019Brien K et al (2021) Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc 18:997\u20131003. https:\/\/doi.org\/10.1513\/AnnalsATS.202009-1175OC","journal-title":"Ann Am Thorac Soc"},{"key":"1160_CR153","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","volume":"160","author":"R-D Treede","year":"2019","unstructured":"Treede R-D, Rief W, Barke A et al (2019) Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the International Classification of Diseases (ICD-11). Pain 160:19\u201327. https:\/\/doi.org\/10.1097\/j.pain.0000000000001384","journal-title":"Pain"},{"key":"1160_CR154","doi-asserted-by":"publisher","first-page":"653","DOI":"10.23736\/S1973-9087.20.06563-6","volume":"57","author":"S Tuzun","year":"2021","unstructured":"Tuzun S, Keles A, Okutan D et al (2021) Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19. Eur J Phys Rehabil Med 57:653\u2013662. https:\/\/doi.org\/10.23736\/S1973-9087.20.06563-6","journal-title":"Eur J Phys Rehabil Med"},{"key":"1160_CR155","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/brain\/awt053","volume":"136","author":"N \u00dc\u00e7eyler","year":"2013","unstructured":"\u00dc\u00e7eyler N, Zeller D, Kahn AK et al (2013) Small fibre pathology in patients with fibromyalgia syndrome. Brain 136:1857\u20131867. https:\/\/doi.org\/10.1093\/brain\/awt053","journal-title":"Brain"},{"key":"1160_CR156","doi-asserted-by":"publisher","first-page":"e001735","DOI":"10.1136\/rmdopen-2021-001735","volume":"7","author":"F Ursini","year":"2021","unstructured":"Ursini F, Ciaffi J, Mancarella L et al (2021) Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open 7:e001735. https:\/\/doi.org\/10.1136\/rmdopen-2021-001735","journal-title":"RMD Open"},{"key":"1160_CR157","doi-asserted-by":"publisher","first-page":"100091","DOI":"10.1016\/j.bbih.2020.100091","volume":"5","author":"H Valiuddin","year":"2020","unstructured":"Valiuddin H, Skwirsk B, Paz-Arabo P (2020) Acute transverse myelitis associated with SARS-CoV-2: a case-report. Brain, Behav Immun Heal. 5:100091. https:\/\/doi.org\/10.1016\/j.bbih.2020.100091","journal-title":"Brain, Behav Immun Heal."},{"key":"1160_CR158","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","volume":"28","author":"FL van de Veerdonk","year":"2022","unstructured":"van de Veerdonk FL, Giamarellos-Bourboulis E, Pickkers P et al (2022) A guide to immunotherapy for COVID-19. Nat Med 28:39\u201350. https:\/\/doi.org\/10.1038\/s41591-021-01643-9","journal-title":"Nat Med"},{"key":"1160_CR159","doi-asserted-by":"publisher","first-page":"100020","DOI":"10.1016\/j.lanepe.2020.100020","volume":"2","author":"TV Varga","year":"2021","unstructured":"Varga TV, Bu F, Dissing AS et al (2021) Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: a longitudinal analysis of 200,000 Western and Northern Europeans. Lancet Reg Heal Eur. 2:100020. https:\/\/doi.org\/10.1016\/j.lanepe.2020.100020","journal-title":"Lancet Reg Heal Eur."},{"key":"1160_CR160","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1378\/chest.15-1271","volume":"149","author":"AE Vertigan","year":"2016","unstructured":"Vertigan AE, Kapela SL, Ryan NM et al (2016) Pregabalin and speech pathology combination therapy for refractory chronic cough a randomized controlled trial. Chest 149:639\u2013648. https:\/\/doi.org\/10.1378\/chest.15-1271","journal-title":"Chest"},{"key":"1160_CR161","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"1160_CR162","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang EY, Mao T, Klein J et al (2021) Diverse functional autoantibodies in patients with COVID-19. Nature 595:283\u2013288. https:\/\/doi.org\/10.1038\/s41586-021-03631-y","journal-title":"Nature"},{"key":"1160_CR163","unstructured":"WHO (2023) Globally confirmed cases of COVID-19. World Health Organization. https:\/\/covid19.who.int\/. Accessed 13 Dec 2021"},{"key":"1160_CR164","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s41983-020-00238-4","volume":"56","author":"IPE Widyadharma","year":"2020","unstructured":"Widyadharma IPE, Dewi PR, Wijayanti IAS, Utami DKI (2020) Pain related viral infections: a literature review. Egypt J Neurol Psychiatry Neurosurg 56:105. https:\/\/doi.org\/10.1186\/s41983-020-00238-4","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"1160_CR165","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC et al (2020a) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324:782\u2013793. https:\/\/doi.org\/10.1001\/jama.2020.12839","journal-title":"JAMA"},{"key":"1160_CR166","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC et al (2020b) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA 324:782. https:\/\/doi.org\/10.1001\/jama.2020.12839","journal-title":"JAMA"},{"key":"1160_CR167","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (hoboken) 62:600\u2013610. https:\/\/doi.org\/10.1002\/acr.20140","journal-title":"Arthritis Care Res (hoboken)"},{"key":"1160_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/J.INTIMP.2020.106210","author":"P Xin","year":"2020","unstructured":"Xin P, Xu X, Deng C et al (2020) The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/J.INTIMP.2020.106210","journal-title":"Int Immunopharmacol"},{"key":"1160_CR169","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/JCPH.1795","volume":"61","author":"C Xu","year":"2021","unstructured":"Xu C, Rafique A, Potocky T et al (2021) Differential binding of sarilumab and tocilizumab to IL-6R\u03b1 and effects of receptor occupancy on clinical parameters. J Clin Pharmacol 61:714\u2013724. https:\/\/doi.org\/10.1002\/JCPH.1795","journal-title":"J Clin Pharmacol"},{"key":"1160_CR170","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","volume":"398","author":"LM Yu","year":"2021","unstructured":"Yu LM, Bafadhel M, Dorward J et al (2021) Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet 398:843\u2013855. https:\/\/doi.org\/10.1016\/S0140-6736(21)01744-X","journal-title":"Lancet"},{"key":"1160_CR171","doi-asserted-by":"publisher","first-page":"61390","DOI":"10.7554\/eLife.61390","volume":"9","author":"N Zamorano Cuervo","year":"2020","unstructured":"Zamorano Cuervo N, Grandvaux N (2020) ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 9:61390. https:\/\/doi.org\/10.7554\/eLife.61390","journal-title":"Elife"},{"key":"1160_CR172","doi-asserted-by":"publisher","first-page":"109022","DOI":"10.1016\/J.CLIM.2022.109022","volume":"239","author":"W Zhang","year":"2022","unstructured":"Zhang W, Qin C, Fei Y et al (2022) Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: an update. Clin Immunol 239:109022. https:\/\/doi.org\/10.1016\/J.CLIM.2022.109022","journal-title":"Clin Immunol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01160-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01160-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T09:29:05Z","timestamp":1682587745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01160-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":172,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01160-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"4 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}